Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy

Cathy Mast, Ramesh K. Ramanathan, Donald I. Feinstein, Peter Rosen

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Both solid and hematologic malignancies may be complicated by coagulopathies. Disseminated intravascular coagulation (DIC) in the presence of pancreatic cancer is generally unrecognized and may have fatal consequences. The diagnosis of DIC in a patient with advanced cancer is a poor prognostic indicator. Presented here is a case study consisting of two patients presenting with a new diagnosis of pancreatic cancer complicated by DIC. Aggressive supportive treatment in addition to systemic chemotherapy consisting of gemcitabine and nabpaclitaxel was initiated and DIC was controlled. An early diagnosis of DIC and the administration of systemic chemotherapy with a high response rate and an ability to reduce tumor bulk rapidly may offer some patients the probability of recovery.

Original languageEnglish (US)
Pages (from-to)266-269
Number of pages4
JournalOncology (Switzerland)
Volume87
Issue number5
DOIs
StatePublished - Nov 19 2014

Keywords

  • Advanced pancreatic cancer
  • Combination chemotherapy
  • Disseminated intravascular coagulation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy'. Together they form a unique fingerprint.

  • Cite this